Symbols / CLDX Stock $34.00 -0.61% Celldex Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
CLDX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Stock Fundamentals
Scroll to Statements
Market Cap 2.67B Enterprise Value 1.76B Income -258.76M Sales 1.54M Book/sh 7.92 Cash/sh 7.79
Dividend Yield — Payout 0.00% Employees 198 IPO — P/E — Forward P/E -7.08
PEG — P/S 1726.70 P/B 4.29 P/C — EV/EBITDA -6.20 EV/Sales 1139.80
Quick Ratio 10.21 Current Ratio 10.48 Debt/Eq 0.44 LT Debt/Eq — EPS (ttm) -3.90 EPS next Y -4.80
EPS Growth — Revenue Growth -89.70% Earnings 2026-05-07 ROA -26.12% ROE -40.62% ROIC —
Gross Margin 0.00% Oper. Margin -720.27% Profit Margin 0.00% Shs Outstand 78.46M Shs Float 61.37M Short Float 16.10%
Short Ratio 9.64 Short Interest — 52W High 35.79 52W Low 17.85 Beta 1.20 Avg Volume 1.04M
Volume 113.95K Target Price $57.00 Recom Strong_buy Prev Close $34.21 Price $34.00 Change -0.61%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-28.80
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest CLDX news

No recent news from Yahoo. Try the RSS feed for latest CLDX news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-02 MARTIN SAMUEL BATES Chief Financial Officer — 4,817 $10.38 $50,000
2025-12-15 PEPIN RONALD A Officer — 19,333 $2.78 $105,714
2025-12-04 JIMENEZ FREDDY A General Counsel — 4,166 $29.10 $121,210
2025-11-13 WRIGHT RICHARD M Former — 49,298 $24.00 $1,183,177
2025-11-13 WRIGHT RICHARD M Former — 49,298 $9.02 $692,913
2025-08-13 JIMENEZ FREDDY A General Counsel — 771 $23.95 $19,096
2024-11-18 MARINO JAMES J Director — 10,500 $0.00 $0
2024-06-14 CROWLEY ELIZABETH Officer — 30,000 $34.87 $1,045,962
2024-06-14 CROWLEY ELIZABETH Officer — 30,000 $10.38 $311,400
2024-06-14 MARTIN SAMUEL BATES Chief Financial Officer — 17,172 $35.42 $608,315
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category